Human Fecal Transplantation Modifies the Gut Microbiota but Not Metabolites in Colon Cancer Patient-Derived Xenografts
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27031438 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Katarzyna Unrug-Bielawska und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Maria Sklodowska-Curie National Research Institute of Oncology, Roentgena 5, 02-781 Warsaw, Poland. Hauptthemen laut MEDLINE: Fecal Microbiota Transplantation, Gastrointestinal Microbiome, Colonic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre.
Abstract (Originalsprache)
Gut microbiota influences colorectal cancer (CRC) development, tumor progression, and response to therapy. Fecal microbiota transplantation (FMT) has been proposed as a strategy to restore microbial balance and modulate treatment outcomes. We evaluated the effects of human fecal transplantation on gut microbiota composition, metabolites, tumor growth, and the efficacy of folinic acid, fluorouracil and oxaliplatin (FOLFOX) chemotherapy in four CRC patient-derived xenograft (CRC PDX) models in NSG mice. Gut microbiota was profiled by 16S rRNA sequencing; short-chain fatty acids (SCFAs) and amino acids (AAs) were analyzed by mass spectrometry. Prolonged FMT significantly altered gut microbiota structure, increasing α-diversity and modifying β-diversity, and induced distinct changes in bacterial genera. FMT alone did not affect tumor growth. FOLFOX inhibited tumor progression in all CRC PDXs, with FMT enhancing therapeutic efficacy in two models. Despite substantial microbiota shifts, FMT exerted minimal or no effect on fecal SCFAs and AAs. FMT induced robust microbiota remodeling but did not modify selected stool metabolites or intrinsic tumor growth. However, FMT enhanced FOLFOX responsiveness in selected CRC PDXs, supporting a microbiota-mediated modulation of chemotherapy outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics, Maria Sklodowska-Curie National Research Institute of Oncology, Roentgena 5, 02-781 Warsaw, Poland.
- Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, Roentgena 5, 02-781 Warsaw, Poland.
ORCID-Profile: Katarzyna Unrug-Bielawska, Paweł Czarnowski, Magdalena Piątkowska, Aneta Bałabas, Izabela Rumieńczyk, Michał Mikula
Förderung
- National Science Centre
Zitieren
APA
Unrug-Bielawska, K., Sandowska-Markiewicz, Z., Kaniuga, E., Cybulska-Lubak, M., Borowa-Chmielak, M., Czarnowski, P., Piątkowska, M., Bałabas, A., Goryca, K., Zeber-Lubecka, N., Kulecka, M., Dąbrowska, M., Surynt, P., Statkiewicz, M., Rumieńczyk, I., Mikula, M., & Ostrowski, J. (2026). Human Fecal Transplantation Modifies the Gut Microbiota but Not Metabolites in Colon Cancer Patient-Derived Xenografts. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27031438
Vancouver
Unrug-Bielawska K, Sandowska-Markiewicz Z, Kaniuga E, Cybulska-Lubak M, Borowa-Chmielak M, Czarnowski P, et al. Human Fecal Transplantation Modifies the Gut Microbiota but Not Metabolites in Colon Cancer Patient-Derived Xenografts. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27031438
BibTeX
@article{UnrugBielawska2026,
author = {Unrug-Bielawska, Katarzyna and Sandowska-Markiewicz, Zuzanna and Kaniuga, Ewelina and Cybulska-Lubak, Magdalena and Borowa-Chmielak, Monika and Czarnowski, Paweł and Piątkowska, Magdalena and Bałabas, Aneta and Goryca, Krzysztof and Zeber-Lubecka, Natalia and Kulecka, Maria and Dąbrowska, Michalina and Surynt, Piotr and Statkiewicz, Małgorzata and Rumieńczyk, Izabela and Mikula, Michał and Ostrowski, Jerzy},
title = {Human Fecal Transplantation Modifies the Gut Microbiota but Not Metabolites in Colon Cancer Patient-Derived Xenografts},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27031438}
}
EUVIMED